ESR1 and breast cancer: Lewińska et al. tested UA against phenotypically distinct BC cells MCF-7 (ER+, PR+/−, HER2−), MDA-MB-231 (ER−, PR−, HER2−), and SK-BR-3 (ER−, PR−, HER2+).